PMVP FY 2023 Earnings — PMV Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

PMVPPMV Pharmaceuticals, Inc.

$88M

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$1M

Operating Income

-$80M

Net Income

-$69M

EPS (Diluted)

$-1.44

Cash Flow

Operating Cash Flow

-$56M

Free Cash Flow

-$57M

Stock-Based Comp.

$12M

Balance Sheet

Total Assets

$252M

Total Liabilities

$26M

Stockholders' Equity

$226M

Cash & Equivalents

$38M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$1M	-$650,000	-93.4%
Operating Income	-$80M	-$77M	-4.0%
Net Income	-$69M	-$73M	+5.9%